688203.SS Stock Analysis
68
Uncovered
Zhejiang Hisun Biomaterials Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Zhejiang Hisun Biomaterials Co Ltd is a CN-based company operating in Chemicals industry. The company is headquartered in Taizhou, Zhejiang and currently employs 360 full-time employees. The company went IPO on 2022-08-16. Zhejiang Hisun Biomaterials Co Ltd is a China-based company principally engaged in the research and development, production and sales of Polylactide (PLA). The firm's main products include polylactic acid in resin form, which can be divided into pure polylactic acid and compound modified polylactic acid. The firm is also engaged in the sale of PLA primary products in the form of powders, films, non-woven fabrics, and others.